PMC:6730630 / 22937-23200 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/6730630","sourcedb":"PMC","sourceid":"6730630","source_url":"https://www.ncbi.nlm.nih.gov/pmc/6730630","text":"Figure 1 ACEI (or ARB) optimisation over the length of the programme compared to baseline.\n*Moderate to severe left ventricular systolic dysfunction patients only; **running total; ACEI, ACE inhibitor; ARB, angiotensin receptor blocker; PDSA, Plan–Do–Study–Act.","divisions":[{"label":"label","span":{"begin":0,"end":8}},{"label":"p","span":{"begin":11,"end":92}}],"tracks":[]}